Skip to main content
SpringerLink
Log in

Update on safety of synthetic and biological DMARDs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sepriano A, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis Annals of the Rheumatic Diseases : 14 Nov 2022. Available from: URL: http://doi.org/10.1136/ard-2022-223357

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Update on safety of synthetic and biological DMARDs. Reactions Weekly 1934, 12 (2022). https://doi.org/10.1007/s40278-022-28393-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28393-9

Search

Navigation